Tianming Du

Tianming Du

Auto-generated profile, based on publicly available information

Tianming Du

Northeastern University

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in BioMed Research International
Verified
Journal Article
Open access
PDF file
TDTianming Du
Tianming Du
HZHai-Dong Zhao
Hai-Dong Zhao
Objective. To use habitat analysis (also termed habitat imaging) for classifying untreated breast cancer‐enhanced magnetic resonance imaging (MRI) in women. Moreover, we intended to obtain clustering parameters to predict the BReast CAncer gene 1 (BRCA1) gene mutation and to determine the use of MRI as a noninvasive examination tool. Methods. We obtained enhanced MRI data of patients with breast cancer before treatment and selected some sequences as the source of habitat imaging. We used the k‐means clustering to classify these images. According to the formed subregions, we calculated several parameters to evaluate the clustering. We used immunohistochemistry to detect BRCA1 mutations. Moreover, we separately determined the ability of these parameters through independent modeling or multiple parameter joint modeling to predict these mutations. Results. Of all extracted values, separation (SP) demonstrated the best prediction performance for a single parameter (area under the receiver operating characteristic curve (AUC), 0.647; 95% confidence interval (CI), 0.557–0.731). Simultaneously, models based on the Calinski‐Harabasz Index and sum of square error performed better in the training (AUC, 0.903; 95% CI, 0.831–0.96) and verification (AUC, 0.845; 95% CI, 0.723–0.942) sets for multiparameter joint modeling. Conclusion. Based on the enhanced MRI of breast tumors and the subregions generated according to the habitat imaging theory, the parameters extracted to describe the clustering effect could reflect the BRCA1 status. Differences between clusters, including the general differences of cluster centers and clusters and the similarity of samples within clusters, were the embodiment of this mutation. We propose an algorithm to predict the BRCA1 mutation of a patient according to the enhanced MRI of the breast tumor.

21 May 2024 in Critical Reviews in Clinical Laboratory Sciences
Verified
Journal Article
Closed access
YGYi Gao
Yi Gao
TDTianming Du
Tianming Du
LYLianbo Yang
Lianbo Yang
LWLina Wu
Lina Wu
This article comprehensively elucidates the discovery of Krebs von den Lungen-6 (KL-6), its structural features, functional mechanisms, and the current research status in various respiratory system diseases. Discovered in 1985, KL-6 was initially considered a tumor marker, but its elevated levels in interstitial lung disease (ILD) led to its recognition as a relevant serum marker for ILD. KL-6 is primarily produced by type 2 alveolar epithelial cell regeneration. Over the past 30 years since the discovery of KL-6, the number of related research papers has steadily increased annually. Following the coronavirus disease 2019 (COVID-19) pandemic, there has been a sudden surge in relevant literature. Despite KL-6's potential as a biomarker, its value in the diagnosis, treatment, and prognosis varies across different respiratory diseases, including ILD, idiopathic pulmonary fibrosis (IPF), COVID-19, and lung cancer. Therefore, as an important serum biomarker in respiratory system diseases, the value of KL-6 still requires further investigation.

1 January 2022 in BioMed Research International
Verified
Journal Article
Open access
PDF file
TDTianming Du
Tianming Du
HZHai-Dong Zhao
Hai-Dong Zhao
Objective. Image texture information was extracted from enhanced magnetic resonance imaging (MRI) and pathological hematoxylin and eosin‐ (HE‐) stained images of female breast cancer patients. We established models individually, and then, we combine the two kinds of data to establish model. Through this method, we verified whether sufficient information could be obtained from enhanced MRI and pathological slides to assist in the determination of epidermal growth factor receptor (EGFR) mutation status in patients. Methods. We obtained enhanced MRI data from patients with breast cancer before treatment and selected diffusion‐weighted imaging (DWI), T1 fast‐spin echo (T1 FSE), and T2 fast‐spin echo (T2 FSE) as the data sources for extracting texture information. Imaging physicians manually outlined the 3D regions of interest (ROIs) and extracted texture features according to the gray level cooccurrence matrix (GLCM) of the images. For the HE staining images of the patients, we adopted a specific normalization algorithm to simulate the images dyed with only hematoxylin or eosin and extracted textures. We extracted texture features to predict the expression of EGFR. After evaluating the predictive power of each model, the models from the two data sources were combined for remodeling. Results. For enhanced MRI data, the modeling of texture information of T1 FSE had a good predictive effect for EGFR mutation status. For pathological images, eosin‐stained images can achieve a better prediction effect. We selected these two classifiers as the weak classifiers of the final model and obtained good results (training group: AUC, 0.983; 95% CI, 0.95‐1.00; accuracy, 0.962; specificity, 0.936; and sensitivity, 0.979; test group: AUC, 0.983; 95% CI, 0.94‐1.00; accuracy, 0.943; specificity, 1.00; and sensitivity, 0.905). Conclusion. The EGFR mutation status of patients with breast cancer can be well predicted based on enhanced MRI data and pathological data. This helps hospitals that do not test the EGFR mutation status of patients with breast cancer. The technology gives clinicians more information about breast cancer, which helps them make accurate diagnoses and select suitable treatments.

23 May 2025
Verified
Book Chapter
Closed access
PDF file
SZShangqi Zhou
Shangqi Zhou
ZWZihao Wang
Zihao Wang
YFYanyu Fu
Yanyu Fu
YWYuzhou Wang
Yuzhou Wang
TDTianming Du
Tianming Du
Hongzan SunHongzan Sun
Hongzan Sun

15 December 2025
Verified
Conference Paper
Closed access
ZWZihao Wang
Zihao Wang
NZNaibo Zhang
Naibo Zhang
TDTianming Du
Tianming Du
YZYujie Zhang
Yujie Zhang
MGMarcin Grzegorzek
Marcin Grzegorzek
CLChen Li
Chen Li
Metabolic syndrome (MetS) is a group of metabolic disorders with insulin resistance at its core, with a high global prevalence, and early screening is crucial for preventing cardiovascular disease. Currently, clinical diagnosis relies on invasive biochemical testing, which is expensive and patient compliance is poor. Infrared thermography (IRT) has the potential to screen for MetS as a non-invasive functional imaging technique, but high-resolution devices are expensive and low-cost devices have low resolution. In this paper, a method combining multimodal imaging and super-resolution reconstruction is proposed to construct a synchronous acquisition system containing low-resolution infrared, high-resolution infrared and visible light images. At the algorithm level, the system evaluates SwinIR and lightweight SRVGG networks to reconstruct a low-resolution image of $32 \times 24$ pixels to $256 \times 192$ pixels. The experimental results show that SwinIR has the best performance in PSNR (30.51 dB) and SSIM (0.872), and SRVGG is still significantly better than the traditional interpolation method despite its light weight (79.1 KB). This study provides an effective technical path to overcome the cost and resolution limitations of infrared equipment, which is helpful to promote the early screening and prevention and control of MetS at the community and family levels.